Tuesday, April 19, 2022

DCGI: Fourfold increase in Investigational New Drugs Applications in India
New Delhi: Claiming that India is on course to become a 'global hub for medicines', Dr VG Somani, Drug Controller General of India (DCGI), said that there has been a fourfold increase in applications of the investigational new drugs in the country.

Speaking at the Indian Drug Manufacturers' Association (IDMA) Annual Conclave, Somani said, "We are getting the applications of the investigational new drugs. Earlier, there used to be hardly 5-10 applications.

At present, there are 23 applications in the pipeline for the investigational new drug and this is a great achievement of our country."

Click for more articles on DCGI

He said that the "Made in India" drugs will make a difference and hit the world in the coming years.

The DCGI official also explained how drug controllers work while taking decisions about vaccines and drugs.

"We have been in regular contact with the WHO and all regulators of the world through ICMR, ICH platform etc.

There are various platforms for the approval of vaccines and drugs including trials. That's what we have done with remdesivir. There is no single platform for decisions to be taken," he added.

He further said that India has been recognised as a "Pharmacy of the world" and added "we want to become the well-managed pharmacy of the entire world so that our potential can be recognised".

4 Medical Devices Parks to come up in a total of 1,326 acres

CDSCO Committee gives approval to Sun Pharma for Ranibizumab

E-Cigarettes using synthetic nicotine come under FDA oversight

USFDA authorises first C-19 diagnostic test using breath samples

Govt wants to ease compliance burden on Pharma Industry

FDA Maharashtra issues show cause notices to 95 Pharma units

NPPA fixes retail price of 23 formulations: April 2022

FDA warns websites illegally selling Amphetamine and Dextroamphetamine

16 Pharma units get ‘stop production orders’ for norm violations

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/04/18/dcgi-fourfold-increase-in-investigational-new-drugs-applications-in-india/

No comments:

Post a Comment